This week’s topics include papers on punishing health care fraud, how physicians interpret research funding disclosures, and the association between BP and mortality in those newly diagnosed with type-2 diabetes.
Archives for September 2012RSS
Xiao Xu examines the unique stressors – both at home and at work – that women and men may face.
A dull press release and dull scientific paper may, in this case, signify genuine progress.
Why I Applaud the Skeptical Physicians (20 Sep 2012)Joseph Ross, MD, MHS
Is skepticism of industry-funded trials warranted even when they are designed, conducted, and reported with the utmost rigor?
A print ad for Niaspan focuses only on how it raises HDL-cholesterol levels, with no mention of the lack of benefit in improving outcomes.
This week’s topics include surgical vs. lifestyle treatment for type-2 diabetes, omega-3 fatty-acid supplementation and the risk for major CVD events, FAME 2, using high-sensitivity cardiac troponin T for one-hour rule-out or rule-in of acute MI, and the timing of acute MI in patients having total hip or knee replacement.
What is the role of a clinician in putting misleading ads in context for patients?
This week’s topics include the safety risks of drugs that have gone through the FDA’s expedited approval program, a Framingham Heart Study paper on aortic stiffness in the elderly, and using CMR to detect previously undetected MI in older adults.
Resuscitating Resuscitation (6 Sep 2012)Brahmajee Kartik Nallamothu, MD, MPH and Zachary Goldberger, MD, MS
Lancet authors Brahmajee Nallamothu and Zarchary Goldberger join CardioExchange to answer questions about their provocative study indicating a correlation between prolonged resuscitation efforts and survival.
This week’s topics includes studies on aspirin plus clopidogrel in patients with recent lacunar stroke and the risk of coronary events in patients with either CKD or diabetes.